Skip to content

Probiotics reduced diarrhea incidence in colorectal cancer chemotherapy trials

Pooled trials reported less diarrhea with probiotics than with controls. An inconsistent diarrhea-duration estimate prevents a reliable interpretation of that separate outcome.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

For colorectal cancer patients receiving chemotherapy, pooled randomized trial results showed less diarrhea with probiotics than with controls. Several other gastrointestinal symptoms reportedly improved, while enteritis and listed laboratory markers showed no statistically clear differences. The abstract cannot reliably quantify diarrhea duration or identify which probiotic products accounted for the reported effects.

Keep in mind

The duration result is labeled as a negative risk ratio, with an interval inconsistent with the claimed significance. Probiotic product details, follow-up length and adverse-event results are absent from the abstract.

THE NUMBERS, WITH CONTEXT

What researchers found

0.51 times the diarrhea incidence in controls

Diarrhea incidence following chemotherapy

Probiotics versus controls: risk ratio 0.51; 95% confidence interval 0.40–0.64. Follow-up length was not reported.

Medicine (Baltimore), 2025 · Original source ↓

Reading the relative comparison

The risk ratio describes diarrhea incidence in the probiotic groups relative to the control groups. It does not tell us how many patients avoided diarrhea. Absolute event rates are not supplied in the abstract.

Other outcomes need separate interpretation

Bloating, nausea or vomiting, appetite loss and abdominal pain reportedly improved. Enteritis and the listed laboratory markers showed no significant differences, which does not establish equivalence. The inconsistent duration estimate leaves episode length unresolved.

CHECK THE ORIGINAL

The original publication

Efficacy and safety of probiotics in preventing chemotherapy-related diarrhea in patients with colorectal cancer: A systematic review and meta-analysis based on 18 randomized trials.

Yang M, Wang L, Luo C et al.
Medicine (Baltimore) · 2025

PubMed ID
40629588
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.